Grove Bank & Trust’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$107K Sell
1,549
-615
-28% -$42.4K 0.01% 329
2025
Q1
$150K Sell
2,164
-10,967
-84% -$762K 0.02% 275
2024
Q4
$1.13M Sell
13,131
-181
-1% -$15.6K 0.16% 94
2024
Q3
$1.59M Buy
13,312
+1,669
+14% +$199K 0.23% 79
2024
Q2
$1.66M Buy
11,643
+840
+8% +$120K 0.27% 70
2024
Q1
$1.39M Buy
10,803
+1,040
+11% +$134K 0.23% 75
2023
Q4
$1.01M Buy
9,763
+4,976
+104% +$515K 0.19% 91
2023
Q3
$435K Buy
+4,787
New +$435K 0.09% 151
2023
Q2
Sell
-138
Closed -$11K 703
2023
Q1
$11K Buy
138
+2
+1% +$159 ﹤0.01% 504
2022
Q4
$9K Buy
+136
New +$9K ﹤0.01% 502
2016
Q3
Sell
-2,516
Closed -$68K 267
2016
Q2
$68K Hold
2,516
0.06% 139
2016
Q1
$68K Sell
2,516
-520
-17% -$14.1K 0.06% 141
2015
Q4
$88K Buy
+3,036
New +$88K 0.08% 137